A08537M Stock Overview
Lutronic Corporation manufactures and sells aesthetic and medical advanced laser, and related technology worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Lutronic Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩55,300.00 |
| 52 Week High | ₩69,000.00 |
| 52 Week Low | ₩27,000.00 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 91.68% |
| 33 Year Change | 290.81% |
| 5 Year Change | 368.64% |
| Change since IPO | 247.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| A08537M | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0% | 7.4% | 1.3% |
| 1Y | 91.7% | 22.6% | 8.4% |
Return vs Industry: A08537M exceeded the KR Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: A08537M exceeded the KR Market which returned 19.9% over the past year.
Price Volatility
| A08537M volatility | |
|---|---|
| A08537M Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in KR Market | 11.0% |
| 10% least volatile stocks in KR Market | 2.3% |
Stable Share Price: A08537M has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine A08537M's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 311 | Hae-Lyung Hwang | int.lutronic.com |
Lutronic Corporation manufactures and sells aesthetic and medical advanced laser, and related technology worldwide. The company provides HOLLYWOOD SPECTRA, a laser platform with proprietary capabilities to reduce unwanted pigmentation and restore glowing skin; Accufit that delivers direct muscle activation treatments for an improved aesthetic appearance; LUTRONIC GENIUS, which delivers precision in every pulse; CLARITY II, a dual wavelength platform laser with breakthrough intelligent capabilities; LaseMD Ultra that provides customized outcomes with virtually no downtime for patients; and SPECTRA XT, a cutting-edge device. It also offers CLARITY, a dual-wavelength platform that enables treatment versatility and greater speed; LASEMD, an extendable platform that is able to provide a cosmeceutical delivery system program for skincare and cure; SPECTRA that provides low-downtime and efficacious treatments; PICOPLUS for the treatment of melasma; and ACTION II, a specialized multiple stacking fractional technology that combines user-selected ablation depth with coagulation control for a virtually painless procedure.
Lutronic Corporation Fundamentals Summary
| A08537M fundamental statistics | |
|---|---|
| Market cap | ₩949.46b |
| Earnings (TTM) | ₩28.70b |
| Revenue (TTM) | ₩273.16b |
33.1x
P/E Ratio3.5x
P/S RatioIs A08537M overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A08537M income statement (TTM) | |
|---|---|
| Revenue | ₩273.16b |
| Cost of Revenue | ₩98.30b |
| Gross Profit | ₩174.86b |
| Other Expenses | ₩146.16b |
| Earnings | ₩28.70b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.11k |
| Gross Margin | 64.01% |
| Net Profit Margin | 10.51% |
| Debt/Equity Ratio | 0% |
How did A08537M perform over the long term?
See historical performance and comparison